RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CSPC Pharmaceutical Group - Stock

CSPC Pharmaceutical Group ROA 2024

CSPC Pharmaceutical Group ROA

0.13

Ticker

1093.HK

ISIN

HK1093012172

WKN

548183

In 2024, CSPC Pharmaceutical Group's return on assets (ROA) was 0.13, a -12.98% increase from the 0.15 ROA in the previous year.

CSPC Pharmaceutical Group Aktienanalyse

What does CSPC Pharmaceutical Group do?

CSPC Pharmaceutical Group Ltd. is a leading pharmaceutical company in China. It was founded in 1997 and specializes in the manufacturing of pharmaceutical raw materials, intermediates, and finished drugs. The company's product range covers various therapy areas and provides a variety of medications for patients worldwide. The company's business model is based on research, development, and production of pharmaceutical products for the mass market. In 2019, CSPC Pharmaceutical achieved a revenue of 9.9 billion USD. The company's products are represented in 24 countries worldwide and aim to improve people's lives through innovations in the healthcare sector. CSPC Pharmaceutical has various divisions, including its sister company CSPC Zhongqi Pharmaceutical Technology Co. Ltd., which specializes in innovative technologies for drug manufacturing. Other divisions include CSPC Weisheng Pharmaceutical Co. Ltd. for marketing and distribution in China, as well as CSPC Ouyi Pharmaceutical Co. Ltd. for the production of traditional Chinese medicines. The product range of CSPC Pharmaceutical is diverse and offers medications for various application areas. This includes cancer therapy with products such as Anastrozole tablets and Vinorelbine injection solution. In the field of cardiovascular diseases, CSPC Pharmaceutical offers Metoprolol Succinate tablets. Additionally, the company provides products for the treatment of pain and inflammation, such as Ibuprofen suspension and generic versions of Celecoxib. Another focus of the company is the research and production of antibiotics, which are important medications in the treatment of bacterial infections. CSPC Pharmaceutical produces a wide range of antibiotics in different dosage forms, including Cefazolin Sodium injection solutions and Cefalotin Sodium injection solutions. Throughout its history, CSPC Pharmaceutical has received various awards and certifications that confirm the high quality of its products. In 2019, the company was honored as the "Best Innovative Pharmaceutical Firm" at the Asia-Pacific Biotech Industry Awards. Furthermore, CSPC Pharmaceutical has obtained the ISO 9001:2015 Quality Management System certificate, and its products are approved by the US FDA, the European Medicines Agency, and the National Medical Products Administration in China. Overall, CSPC Pharmaceutical is an important player in the Chinese pharmaceutical market, offering a wide product range and increasing the level of innovation through research and development. With its continuous growth and efforts towards quality and innovation, CSPC Pharmaceutical will continue to play a significant role in the global healthcare market. CSPC Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding CSPC Pharmaceutical Group's Return on Assets (ROA)

CSPC Pharmaceutical Group's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing CSPC Pharmaceutical Group's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider CSPC Pharmaceutical Group's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in CSPC Pharmaceutical Group’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about CSPC Pharmaceutical Group Stock

What is the Return on Assets (ROA) of CSPC Pharmaceutical Group this year?

The Return on Assets (ROA) of CSPC Pharmaceutical Group is 0.13 undefined this year.

What was the ROA of CSPC Pharmaceutical Group compared to the previous year?

The ROA of CSPC Pharmaceutical Group has increased by -12.98% compared to the previous year.

What consequences do high ROA have for investors of CSPC Pharmaceutical Group?

A high ROA is advantageous for investors of CSPC Pharmaceutical Group, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in CSPC Pharmaceutical Group?

A low ROA can be unfavorable for investors of CSPC Pharmaceutical Group as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of CSPC Pharmaceutical Group affect the company?

An increase in ROA of CSPC Pharmaceutical Group can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of CSPC Pharmaceutical Group impact the company?

A reduction in the ROA of CSPC Pharmaceutical Group can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of CSPC Pharmaceutical Group?

Some factors that can influence the ROA of CSPC Pharmaceutical Group include revenue, operating costs, asset structure, and industry average.

Why is the ROA of CSPC Pharmaceutical Group important for investors?

The ROA of CSPC Pharmaceutical Group is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can CSPC Pharmaceutical Group take to improve ROA?

To improve ROA, CSPC Pharmaceutical Group can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does CSPC Pharmaceutical Group pay?

Over the past 12 months, CSPC Pharmaceutical Group paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 4.32 %. For the coming 12 months, CSPC Pharmaceutical Group is expected to pay a dividend of 0.28 CNY.

What is the dividend yield of CSPC Pharmaceutical Group?

The current dividend yield of CSPC Pharmaceutical Group is 4.32 %.

When does CSPC Pharmaceutical Group pay dividends?

CSPC Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of July, October, June, July.

How secure is the dividend of CSPC Pharmaceutical Group?

CSPC Pharmaceutical Group paid dividends every year for the past 17 years.

What is the dividend of CSPC Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.28 CNY are expected. This corresponds to a dividend yield of 4.86 %.

In which sector is CSPC Pharmaceutical Group located?

CSPC Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von CSPC Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CSPC Pharmaceutical Group from 6/26/2024 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did CSPC Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of CSPC Pharmaceutical Group in the year 2023?

In the year 2023, CSPC Pharmaceutical Group distributed 0.2 CNY as dividends.

In which currency does CSPC Pharmaceutical Group pay out the dividend?

The dividends of CSPC Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CSPC Pharmaceutical Group

Our stock analysis for CSPC Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSPC Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.